toxicities

1:20
Exploring the link between chemotherapy-induced toxicities
Rachel Gibson
4:36
Overview of symposium focused on chemotherapy and irritable bowel syndrome
Jervoise Andreyev
1:50
Late psychological and physical burdens in adults diagnosed in childhood
Martin Schrappe
1:20
The crossroads of targeted therapy and immunotherapy in lung cancer
Roy Herbst
3:47
Bone-migrated prostate cancer and Radium-223 therapy
Neal Shore
1:11
Results of trial of ribociclib with everolimus and exemestane in breast cancer
Mafalda Olivera
2:12
Two trials, SOFT and TEXT, investigating combination treatments for patients with breast cancer
Antonio Llombart
1:28
Key messages from the SCLC session at NCRI 2016
Corinne Faivre-Finn
2:56
Perspective on immune modulation to fight cancer
Lieping Chen
1:49
Overview of the CONVERT trial in LS-SCLC
Corinne Faivre-Finn
2:28
How to monitor and manage immunotherapy related events in lung cancer
Alex Spira
4:15
The toxicities associated with immunotherapy in lung cancer patients
Beth Eaby-Sandy
5:15
Results of ASCEND-4 trial of ceritinib versus chemotherapy in ALK+ NSCLC patients
Gilberto De Castro Jr
0:38
Referring cancer patients to exercise professionals
Karen Mustian
1:56
Symptom clusters and oral oncology perspectives
Douglas Peterson
2:30
The impact of supportive care on cancer survivability
Stephen Sonis
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals